Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center: Attorney General Nominee Likely to Challenge Legalized Marijuana
  • USA - English


News provided by

JoTo PR

Jan 03, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Kent Runyon, Compliance Officer and VP of Community Relations for Novus Medical Detox Center, analyzes impacts of legalized marijuana
Kent Runyon, Compliance Officer and VP of Community Relations for Novus Medical Detox Center, analyzes impacts of legalized marijuana

NEW PORT RICHEY, Fla. (PRWEB) January 03, 2017 -- While 29 states have legalized medical marijuana and a small but growing number permit recreational use, political observers have suggested the new U.S. Attorney General nominee, Jefferson (“Jeff”) Beauregard Sessions III, is likely to challenge legalization.(1, 2) Novus Medical Detox Center, a leading Florida-based drug treatment facility, shares Sessions’ concerns regarding the dangers of legalized marijuana and examines the changes that may follow his appointment.

Despite the legalization of marijuana in a growing number of states, cannabis is still classified as a Schedule I substance with high potential for abuse.

Post this

The legal marijuana industry is currently estimated at $6.7 billion; by 2020, it is expected to approach $22 billion.(1) Other sources have indicated that figure is poised to reach $50 billion within the next 10 years.(2) However, Sessions has criticized marijuana law reform as a “tragic mistake,” and has openly stated that marijuana is “a very real danger” that is “not the kind of thing that ought to be legalized”.(1) Analysis of Sessions’ nomination suggests a “coming war on legal marijuana” in which the new Attorney General “will be able to act decisively and quickly” on drug enforcement, which could including arresting growers, retailers and users.(1)

“Despite the legalization of marijuana in a growing number of states, cannabis is still classified as a Schedule I substance with high potential for abuse,” noted Kent Runyon, Compliance Officer and Vice President of Community Relations for Novus Medical Detox Center. “From a public health and safety perspective, Senator Sessions is justified in his concerns over the proliferation of legal marijuana.”

Runyon emphasizes that evidence shows numerous downsides associated with marijuana use and legalization:

Public Safety Issues: Marijuana is the illicit drug found most often in the blood of drivers involved in accidents, and studies found marijuana-impaired drivers were about twice as likely to be responsible for a fatal accident than drivers without drugs or alcohol in their system.(3) Another study found that workers who tested positive for marijuana in pre-employment drug tests had 55% more industrial accidents and 85% more injuries than those who tested negative.(3)

Health Risks to Users: Research confirms that marijuana can cause many adverse health effects, from harming brain development in babies and causing IQ loss in adolescents to impairing memory, learning, balance and respiratory health in users of all ages. It can also elevate heart rate and blood pressure, increasing users’ risk of heart attack by nearly 5 times in the first hour after smoking.(3)

Harm to Children: A new study from Colorado revealed that unintentional pediatric exposure to marijuana has increased significantly since the state legalized recreational cannabis use in 2012. Regional poison center cases increased more than 5-fold from 2009 to 2015, while the rate of cannabis-related pediatric hospital admissions nearly doubled over a four-year period.(4)

Increased Use and Dependency: Research suggests that 30% of cannabis users may have some degree of marijuana use disorder, and 1 in 10 will become dependent on the drug; as of 2014, nearly 4.2 million Americans were abusing or dependent on cannabis.(3) Economists estimate that marijuana use will increase 75% to 289% following legalization, which could result in 13 million to nearly 48 million new users.(5)

Unanticipated Costs: Healthcare costs are likely to increase with rising cannabis use, given its associated health and safety risks; in addition, some experts estimate that marijuana treatment admissions will grow by 1.3 million to 4.8 million following legalization.(5) And while states that legalize marijuana anticipate new tax revenues, Colorado actually experienced a $5.7 million budget shortfall because of medical marijuana regulation.(5)

“These are just a few examples of how legalized marijuana can cause more harm than good,” said Runyon. “Given these findings and Senator Sessions’ vocal opposition to cannabis, it would be wise for state agencies, cannabis-related businesses and current users to proceed with caution, even in states where marijuana is presently legal.”

Novus offers medically supervised drug detox programs designed to minimize the discomfort of withdrawal. The Florida detox facility provides customized treatment plans based on proven medical protocols, including 24-hour access to nursing care and withdrawal specialists. Novus is renowned for its expertise in treating high-dose methadone cases, and is proficient in detoxing patients from other substances just as safely, comfortably and effectively.

For more information on Novus Medical Detox Center and its alcohol and drug treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today, and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit http://novusdetox.com.

1. Higdon, James. “Jeff Sessions’ Coming War on Legal Marijuana”; POLITICO; December 5, 2016. politico.com/magazine/story/2016/12/jeff-sessions-coming-war-on-legal-marijuana-214501

2. Alsever, Jennifer. “Cannabis Business Hype Is About to Go Up in Smoke”; Fortune; December 2, 2016. fortune.com/2016/12/02/cannabis-business-hype/

3. National Institute on Drug Abuse; National Institutes of Health. Research Report Series: Marijuana; revised August 2016. drugabuse.gov/publications/research-reports/marijuana/

4. Wang, George Sam; Marie-Claire Le Lait; Sara J. Deakyne. “Unintentional Pediatric Exposures to Marijuana in Colorado, 2009–2015”; Journal of the American Medical Association; September 6, 2016. jamanetwork.com/journals/jamapediatrics/article-abstract/2534480

5. Evans, David G. “The Economic Impacts of Marijuana Legalization”; The Journal of Global Drug Policy and Practice; December 30, 2013. globaldrugpolicy.org/Issues/Vol%207%20Issue%204/The%20Economic%20Impacts%20of%20Marijuana%20Legalization%20final%20for%20journal.pdf

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.